Healthbare Region Berlin-Brandenburg
The company has been founded in 2012 in Munich, Germany.In January 2014 the PharmACT AG has relocated from Munich to Berlin-Brandenburg, located in the EUROPARC Dreilinden, in the southwest area of the city of Berlin.
Continouly the management team will be expanded. In 2014 the diabetologist, Prof. Andreas Pfützner, MD, PhD could be obtained for the management board of the company. He has more than 15 years of experience in clinical research, realizing clinical studies and a lot more. For the company a reason to be secure getting the approval of the medicine at the Federal Drug Agency (FDA), the US, and the European Medicines Agency (EMEA), Europe within a short period of time.
In Q4.2014 the operational start of the developement laboratory has been established in Mainz. After regulatory approval of the production area we will start with the commercialization of BelACT.
The first new product is BelDIA PRE, is a risk screening test for measurement of intact proinsulin in human capillary blood. The product is available in the European Union, Egypt and other Mediteranien Countries.
PharmACT AG is privately funded and independent.